Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade - Wikidata - wikimedia - TriplyDB

Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade

Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade

http://www.wikidata.org/entity/Q35178731

about

Compensatory angiogenesis and tumor refractoriness Receptor tyrosine kinase-mediated angiogenesis A phase I, open-label study of trebananib combined with sorafenib or sunitinib in patients with advanced renal cell carcinoma Overexpression of angiopoietin-1 reduces doxorubicin-induced apoptosis in cardiomyocytes Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease.Oscillation of angiogenesis with vascular dropout in diabetic retinopathy by VESsel GENeration analysis (VESGEN)Prognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2.Angiopoietins promote ovarian cancer progression by establishing a procancer microenvironment.Selective killing of tumor neovasculature paradoxically improves chemotherapy delivery to tumors.Primary monocytes regulate endothelial cell survival through secretion of angiopoietin-1 and activation of endothelial Tie2 Future directions in renal cell carcinoma: 2011 and beyond Vasculotide, an Angiopoietin-1 mimetic, ameliorates several features of experimental atopic dermatitis-like disease.Paracrine effect of GTP cyclohydrolase and angiopoietin-1 interaction in stromal fibroblasts on tumor Tie2 activation and breast cancer growth.Glipizide suppresses prostate cancer progression in the TRAMP model by inhibiting angiogenesis Aflibercept and Ang1 supplementation improve neoadjuvant or adjuvant chemotherapy in a preclinical model of resectable breast cancer.Controlling escape from angiogenesis inhibitors.Angiopoietin-1 protects myocardial endothelial cell function blunted by angiopoietin-2 and high glucose condition.Simultaneous targeting of TNF and Ang2 with a novel bispecific antibody enhances efficacy in an in vivo model of arthritis.Angiogenesis in spontaneous tumors and implications for comparative tumor biology.

P2860

Q26851916-16880612-9F9F-49C5-9A96-861CE7758037 Q27001612-3C8A978A-8D3F-43D6-8850-FD1C02D45AC7 Q28304566-84317CFF-7068-4DC1-AC17-4ADF573BA2BC Q28395625-2AFBD34E-C5CD-48BC-B8D1-9E64051D2D85 Q30315828-91A23DBB-D707-4A56-B06A-12F3B2157AF8 Q33847442-D4FD027B-396B-40C9-A6C7-B8447FE217AD Q33908508-E741BCBC-9997-467A-8A5A-BC42BC697365 Q33978086-504574C8-1FF3-46BC-AD1C-4909FAAC5DD9 Q34682223-E4792905-F5FB-4EF9-BD72-254F63D16CBE Q35013388-00E1C8EF-9557-40CC-9805-ED1A90AC4751 Q35152107-31156162-C41D-48A3-8141-D7DD8050DBE8 Q36033171-99ACB47D-4F64-4FBB-AB68-D5295EE1FB09 Q36962605-87EB9AD1-EABB-4A88-8999-77F3301FF5A2 Q36996141-F3E9BCC5-0A8D-49F8-A85E-4372821E8EB5 Q37411781-FBDBEE6D-D268-452B-A2D0-AD9F6DCD6531 Q37672654-0942C31C-27B0-4493-95F8-44D742E3E12C Q37729840-DE7590C4-76D1-4943-8B29-41F2B2ED2FE8 Q39302290-0C82D7B9-F35D-4341-9EC5-4A5B95B843FD Q51301228-22B8090F-C33E-44AA-B4BF-3CB1CD180636

P2860

Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade

http://www.wikidata.org/entity/Q35178731

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Angiopoietin-1/Tie-2 activatio ...... or growth during VEGF blockade

@ast

Angiopoietin-1/Tie-2 activatio ...... or growth during VEGF blockade

@en

type

label

Angiopoietin-1/Tie-2 activatio ...... or growth during VEGF blockade

@ast

Angiopoietin-1/Tie-2 activatio ...... or growth during VEGF blockade

@en

prefLabel

Angiopoietin-1/Tie-2 activatio ...... or growth during VEGF blockade

@ast

Angiopoietin-1/Tie-2 activatio ...... or growth during VEGF blockade

@en

P1433

Q35178731-84BA53F5-0B64-4D11-BA1F-A837AB782077

P1476

Q35178731-8C693750-1599-4D26-8337-FB375B3DC216

P2093

Q35178731-00C9F267-112F-4B67-9A76-F2615DB7F2C4

Q35178731-09DB6599-C00C-4545-9F00-82989DE2B485

Q35178731-16D7F533-EEFA-4B24-AB17-81418D1F689C

Q35178731-26FBCC02-4B3D-47EB-BD36-D31ED820BFAF

Q35178731-2D51C8F0-2AB9-4D32-8CDF-1AAE9263A80E

Q35178731-4B341DD6-88AF-4901-9602-05D0D2419C6B

Q35178731-5896FC5C-6F6A-497A-BCA3-50B686E9756E

Q35178731-63674A18-85F8-4906-A33B-0EBF598E3AB9

Q35178731-7CB30296-D14B-4F6E-A409-106D0C13F1FD

Q35178731-975DE5A9-0808-45E8-9C77-1F0724588DC4

P2860

Q35178731-01C444FC-6D18-48AF-B620-BC8C68A28967

Q35178731-0B017874-B931-4A5D-8712-F6BB6B0E6039

Q35178731-1164B5F3-47F1-4E01-BD56-CB82E3E3352E

Q35178731-12D33E0E-D2EC-4636-8C58-BE3245806190

Q35178731-16DDB2DE-4C31-43BC-9B01-E7EE4706B08D

Q35178731-190247F6-D15F-4E23-B546-097519E6650F

Q35178731-1F504D8D-F89B-40A8-8540-0358E2C6EA3E

Q35178731-29F715FA-D374-4872-B241-BF53D2C059F7

Q35178731-369335B7-0A00-4475-8AA9-D21ADADCF787

Q35178731-422D5B74-5855-4CCC-B249-8343E3FE7340

P304

Q35178731-9DECB409-28C7-428D-AB04-65B4018A3A9D

P31

Q35178731-59ED785A-AD80-4AA8-B5A7-DCE2B0262130

P433

Q35178731-104019D5-E642-4E4F-AEA6-247AD202A91D

P478

Q35178731-C43F0C4E-2018-41EC-9449-94EBB387D2E7

P577

Q35178731-8405EDD7-2FE4-422C-A29D-8DF017437643

P698

Q35178731-0891C9B3-584B-4880-83B2-EF70C7C2F002

P932

Q35178731-FBA982A6-493E-4539-8914-B6F6181CCFAD

P1433

International Journal of Oncology

P1476

Angiopoietin-1/Tie-2 activatio ...... or growth during VEGF blockade

@en

P2093

Alice Lee

http://www.w3.org/2001/XMLSchema#string

Angela Kadenhe-Chiweshe

http://www.w3.org/2001/XMLSchema#string

Darrell J Yamashiro

http://www.w3.org/2001/XMLSchema#string

Elena Burova

http://www.w3.org/2001/XMLSchema#string

Ella Ioffe

http://www.w3.org/2001/XMLSchema#string

Gavin Thurston

http://www.w3.org/2001/XMLSchema#string

George D Yancopoulos

http://www.w3.org/2001/XMLSchema#string

Jae-O Bae

http://www.w3.org/2001/XMLSchema#string

Jessica J Kandel

http://www.w3.org/2001/XMLSchema#string

Jianzhong Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1

Vascular-specific growth factors and blood vessel formation

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF.

Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways.

Regression of established tumors and metastases by potent vascular endothelial growth factor blockade.

Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth.

P304

79-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19082480

http://www.w3.org/2001/XMLSchema#string

P932

3160826

http://www.w3.org/2001/XMLSchema#string